Clinical Trial Update: Evaluation of the Antibody Persistence Beyond Five Years After Immunization With MenFiveTM (NmCV-5), a Pentavalent Meningococcal ACYWX Conjugate Vaccine

View source ↗

Summary

An update on a clinical trial evaluating antibody persistence beyond five years after vaccination with MenFive (NmCV-5), a pentavalent meningococcal ACYWX conju…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• MenFive (NmCV-5)

Snippet

Sponsor: Serum Institute of India Pvt. Ltd. | Conditions: Meningoccocal Disease | Status: NOT_YET_RECRUITING